Evaluating Korean medicine for treating Bell's palsy
Official title: The Effectiveness and Safety of Integrative Korean Medicine Treatment for Bell's Palsy : A Prospective Observational Preliminary Study
Run by Jaseng Medical Foundation · NCT04905745 · Data updated 2026-11-12
This study is testing if Korean medicine can help adults with Bell's palsy improve their facial function and overall condition over three months.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 19 Years to 69 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Jaseng Medical Foundation Academic / other |
| Locations | 1 site (Seoul, Gangnam-Gu) |
| Status | Recruiting |
| Started | May 25, 2021 |
| Main results expected | August 31, 2027 |
| Study ends | August 31, 2027 |
| Registry record updated | February 25, 2026 |
| Trial ID | NCT04905745 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 19 to 69 who have been diagnosed with unilateral peripheral facial nerve palsy within the last three weeks.
✕Probably not a fit
Patients with central nervous system diseases or those who have received significant prior treatments for facial paralysis may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study assesses the effectiveness and safety of Korean integrative treatments in patients diagnosed with peripheral facial nerve palsy. A total of 100 adult participants, aged 19 to 69, will be enrolled and monitored for changes in their condition using the Facial Disability Index (FDI) over a three-month period. The treatment approach will be tailored by experienced clinicians based on individual patient needs, with weekly visits during treatment and follow-up assessments at specified intervals. Data will be collected to evaluate the outcomes of the interventions provided.
Why it matters
Potential benefit: If successful, this study could offer a new effective treatment option for patients suffering from Bell's palsy.
How similar studies have gone: While this approach is relatively novel, other studies have explored integrative medicine for various conditions, showing promising results.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. age of 19 to 69 2. diagnosed with unilateral peripheral facial nerve palsy 3. onset of facial palsy within 3 weeks or less. 4. an individual who can provide written consent form to participate in the study. Exclusion Criteria: 1. diagnosed with central nervous system disease causing facial palsy 2. secondary facial palsy after multiple sclerosis, tumor, cerebrovascular disease and temporal bone fracture. 3. Ramsay-Hunt syndrome 4. bilateral or recurrent facial nerve palsy. 5. an individual who received any treatment that can have a significant effect on changes in facial paralysis within recent 2 month. (ie. facial nerve decompression surgery) 6. already or planned to be pregnant or breast-feeding within the study period. 7. uncontrolled diabetes mellitus within the last 3 months. 8. within a month after participating any other facial palsy-related clinical trials, or planning to participate other clinical trials within 6 month. 9. impossible to read and understand the documents, regarding informed consent form and the questionnaires. 10. difficult to participate according to the judgement of researchers.
Where it's running
-
Jaseng Hospital of Korean Medicine
Seoul, Gangnam-Gu, South Korea Recruiting
Study contacts
- Study coordinator: In-Hyuk Ha, KMD,Ph.D
- Email: hanihata@gmail.com
- Phone: +82-2-2222-2740
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Intradermal acupuncture for ocular surface problems after intractable facial paralysis
This study will test whether tiny needles placed just under the skin can improve dry eye and other ocular surface symptoms in adults with persistent peripheral facial paralysis.
-
Exploring the link between facial paralysis and homocysteine levels
This study looks at whether higher levels of a substance in the blood called homocysteine are linked to Bell's palsy in adults who suddenly experience facial weakness or paralysis.
-
Ultrasound-guided pharmacopuncture as an addition to Korean medicine for back-to-back tension-type headaches after a traffic accident
This study tests whether adding ultrasound-guided pharmacopuncture helps inpatients with tension-type headaches after a traffic accident, compared with standard integrative Korean medicine treatment.
-
Pharmacopuncture vs. physical therapy for chronic lumbar radiculopathy
This pragmatic trial tests whether pharmacopuncture can help people with chronic lumbar radiculopathy as well as or better than physical therapy.
-
Ultrasound-guided Pharmacopuncture for Spinal Pain in Korea
This registry follows patients with spinal pain to see if ultrasound-guided pharmacopuncture is safe and helps reduce pain.
-
JHG002 pharmacopuncture versus TENS for chronic low back pain
This trial will test whether JHG002 pharmacopuncture reduces pain more than standard physical therapy with TENS in adults with chronic low back pain lasting at least six months.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.